ʻO Cleveland Clinic Diabetes Therapeutics, Technology and Surgery 2021
E kiʻi ʻoe i ka link VIA LIFETIME DOWNLOAD LINK (FAST SPEED) MA hope o ka uku
No nā makahiki he iwakāluakūmālima, Cleveland ke Kalinika ʻo ia ke poʻo o ka mālama ʻana i ka maʻi diabetes, ka noiʻi a me ka hoʻonaʻauao. Ua hoʻolālā ʻia kāna kumu kula honua ʻO nā lāʻau lapaʻau maʻi diabetes, ʻenehana a me ka ʻoki ʻana e hāʻawi i nā loiloi hou o nā hoʻolālā hoʻokele a me ka noiʻi e pili ana i nā pilikia o kēia maʻi. Loaʻa iā ia kahi loiloi kikoʻī o nā koho therapeutic e pili ana i ka maʻi diabetes type 1 a me ke ʻano 2, a me kā lākou hoʻopiʻi.
La Diabetes, Therapeutics, Technology and Surgery, ua hōʻike ʻia e ka Cleveland Clinic Department of Endocrinology, Diabetes and Metabolism e hāʻawi i nā loiloi hou o nā hoʻolālā hoʻokele a me ka noiʻi ʻana i nā pilikia o ka maʻi diabetes. ʻO nā kumuhana koʻikoʻi e kamaʻilio ʻia me ka loiloi o nā koho therapeutic no ka mālama ʻana i ka maʻi diabetes type 1 a me 2 a me nā hoʻopiʻi, e komo pū me ka hoʻomaʻamaʻa ʻana i ka pauma, nā lāʻau lapaʻau ʻelua, sulfonylureas, GLP1 agonists, metformin, a me ka hana o ka hoʻoikaika kino a me ka hoʻokē ʻai. ʻO ka mea hou i kēia makahiki kahi kūkākūkā o ka hopena pathophysiologic o COVID-19. ʻO ka pahuhopu o kēia papa ʻo ia ka hoʻonui ʻana i ka mākaukau o ka poʻe hoʻomaʻamaʻa a me ka hana lapaʻau e mālama i ka maʻi diabetes a me kona mau pilikia a, ʻo ka hopena, e hoʻomaikaʻi i nā hopena maʻi.
Ma waho aʻe o ka loaʻa ʻana o nā kiʻi paheʻe haʻiʻōlelo ma mua a ma hope o ka papa, e hāʻawi ʻia i nā poʻe komo ke komo i ka papa hoʻopaʻa hoʻopaʻa leo ola.
Ma hope o ke komo ʻana i kēia haʻawina live stream, hiki i nā mea hoʻomaʻamaʻa ke:
- E wehewehe i ka maikaʻi a me nā hopena ʻaoʻao o nā hoʻoponopono lapaʻau no ka maʻi maʻi type 1, e pili ana i nā pamu insulin pani pani, ʻelua hormone therapy, a me ka glucagon.
- E hoʻohālikelike i ka maikaʻi o nā lāʻau lapaʻau hou a me nā mea e puka mai nei no ka maʻi diabetes type 1 a me 2.
- E noʻonoʻo koʻikoʻi i ka hopena o ke kaʻina bariatric i nā poʻe maʻi me ka maʻi diabetes type 2.
- E wehewehe i nā koho no ka mālama ʻana i nā keiki me ka maʻi diabetes type 2.
- Hoʻohālikelike i ka ʻikepili e pili ana i ka pono o nā meaʻai a me ka hoʻoikaika kino i nā hoʻolālā diabetes.
- E hōʻuluʻulu i ka noiʻi e wehewehe ana i ka hopena pathophysiologic o ka steatohepatitis nona ka waiʻona.
- E wehewehe i ka hopena o ka COVID-19 i ka holomua o ka maʻi maʻi i nā maʻi maʻi.
ʻO Cleveland Clinic Diabetes Therapeutics, Technology and Surgery
Kau 1: Kihi Diabetes Type 1
Pum Hou | Diana Isaacs, PharmD, BCPS, BC-ADM, CDE |
Na Pum Homona Palua | ʻO Keren Zhou, MD |
Hana ʻoe iā ʻoe iho ʻenehana | ʻO Julia Blanchette, PhD, RN, CDCES |
Nā Insulin Hou | ʻO Robert S. Zimmerman, MD |
Ka wanaʻao o Glucagon | Vinni Makin, MD |
Kau 2: E nānā i ka maʻi diabetes type 2
ʻO nā hopena o ka maʻi maʻi maʻi o ka Bariatric Surgery i nā maʻi me ka momona a me ka maʻi diabetes | Ali Aminian, MD |
Palekana anei ka Sulfonyureas? | Pratibha Rao, MD |
Lapaʻau ʻana i ka maʻi diabetes type 2 i nā keiki | Jamie Wood, MD |
Nā Koho Lapaʻau Hou no ka maʻi maʻi maʻi a me ka ʻōpū | Alexandra Mikhael, MD |
Nā Agonists GLP-1: Oral VS. SubQ | ʻO Mario Skugor, MD |
ʻO ka maʻi ʻaʻa momona momona ʻole (NAFLD) kahi hōʻike mua o ka Metabolic Syndrome | ʻO Adi Mehta, MD |
ʻO ka mālama ʻana i ka Hyperlipidemia ma ke ʻano maʻi maʻi type 2: Nānā i nā alakaʻi o kēia manawa | ʻO Dennis Bruemmer, MD, PhD |
Session 3: ʻO ka hoʻokē ʻai, Metformin a me nā pilikia hoʻokele
ʻO ka hoʻokē ʻai a me ka maʻi diabetes: he aha ka hōʻike? | Carolyn Garvey, RDN, LD, CDCES |
Hooponopono i ka Hypoglycemia Post Gastric Bypass | ʻO Sangeeta Kashyap, MD |
Ke kuleana o ka hoʻoikaika kino i ka mālama ʻana i ka maʻi diabetes | ʻO Oscar Morey Vargas, MD |
ʻO ka hoʻomaopopo ʻana i nā hana a Metformin ma o nā pilina ma ka ʻōpū | ʻO Leann Olansky, MD |
T2D a me CVD: Metformin Monotherapy | Kevin M. Pantalone, DO, ECNU, MAKA |
ʻO ka mālama ʻana i ka maʻi diabetes i nā maʻi me COVID-19 | Sana Hasan, DO |
Mahele Endoscopic a me ka ʻokiʻoki o ka Gastric Pylorus no Gastroparesis | Joshua Landreneau, MD |
Release Ka lā: 7/1/21